全文获取类型
收费全文 | 119898篇 |
免费 | 9174篇 |
国内免费 | 3168篇 |
专业分类
耳鼻咽喉 | 512篇 |
儿科学 | 1853篇 |
妇产科学 | 1345篇 |
基础医学 | 5877篇 |
口腔科学 | 1896篇 |
临床医学 | 11540篇 |
内科学 | 16380篇 |
皮肤病学 | 956篇 |
神经病学 | 3809篇 |
特种医学 | 2371篇 |
外国民族医学 | 7篇 |
外科学 | 11988篇 |
综合类 | 22522篇 |
现状与发展 | 10篇 |
一般理论 | 24篇 |
预防医学 | 10076篇 |
眼科学 | 1093篇 |
药学 | 12339篇 |
327篇 | |
中国医学 | 24028篇 |
肿瘤学 | 3287篇 |
出版年
2024年 | 404篇 |
2023年 | 2253篇 |
2022年 | 3474篇 |
2021年 | 5353篇 |
2020年 | 5022篇 |
2019年 | 5656篇 |
2018年 | 4685篇 |
2017年 | 4790篇 |
2016年 | 3962篇 |
2015年 | 3707篇 |
2014年 | 8661篇 |
2013年 | 7370篇 |
2012年 | 7687篇 |
2011年 | 7892篇 |
2010年 | 6323篇 |
2009年 | 5202篇 |
2008年 | 4719篇 |
2007年 | 4942篇 |
2006年 | 3971篇 |
2005年 | 3337篇 |
2004年 | 2648篇 |
2003年 | 2204篇 |
2002年 | 1707篇 |
2001年 | 1512篇 |
2000年 | 1227篇 |
1999年 | 919篇 |
1998年 | 733篇 |
1997年 | 667篇 |
1996年 | 495篇 |
1995年 | 457篇 |
1994年 | 402篇 |
1993年 | 309篇 |
1992年 | 287篇 |
1991年 | 232篇 |
1990年 | 173篇 |
1989年 | 146篇 |
1987年 | 132篇 |
1985年 | 1513篇 |
1984年 | 2528篇 |
1983年 | 2324篇 |
1982年 | 1749篇 |
1981年 | 1842篇 |
1980年 | 1531篇 |
1979年 | 1329篇 |
1978年 | 1151篇 |
1977年 | 665篇 |
1976年 | 1106篇 |
1975年 | 980篇 |
1974年 | 814篇 |
1973年 | 780篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
51.
New Zealand Emergency Medicine Network: A collaboration for acute care research in New Zealand 下载免费PDF全文
The specialty of emergency medicine in Australasia is coming of age. As part of this maturation there is a need for high‐quality evidence to inform practice. This article describes the development of the New Zealand Emergency Medicine Network, a collaboration of committed emergency care researchers who share the vision that New Zealand/Aotearoa will have a world‐leading, patient‐centred emergency care research network, which will improve emergency care for all, so that people coming to any ED in the country will have access to the same world‐class emergency care. 相似文献
52.
Mónica Berger-González Ana Vides-Porras Sarah Strauss Michael Heinrich Simeón Taquirá Pius Krütli 《Medical anthropology》2016,35(4):353-367
Biomedicine fosters particular styles of interaction and behaviors, with the therapeutic relationship seen as occurring between a doctor and patient. In contrast, where alternative modalities of healing are practiced, relationships go beyond a dyadic interaction and include wider social networks. In this article, we propose the existence of a ‘therapeutic unit’ in Maya healing practices in Guatemala that binds healer, wellness seeker, family, and community members, along with the spiritual and natural realms, into a coherent system requiring all of these elements to achieve success. Drawing on interviews with 67 Maya healers, we describe healers’ understanding of raxnaq’il nuk’aslemal (well-being), and show how these interactions activate wider networks that play crucial roles during treatments. We highlight how holism is expressed in relationships typical of indigenous healing systems, and how an appreciation of this is important for developing culturally appropriate health care provision systems. 相似文献
53.
Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of cancer-related mortality within the next decade, with limited effective treatment options and a dismal long-term prognosis for patients. Genomic profiling has not yet manifested clinical benefits for diagnosis, treatment or prognosis in PDAC, due to the lack of available tissues for sequencing and the confounding effects of low tumour cellularity in many biopsy specimens. Increasing focus is now turning to the use of minimally invasive liquid biopsies to enhance the characterisation of actionable PDAC tumour genomes. Circulating tumour DNA (ctDNA) is the most comprehensively studied liquid biopsy analyte in blood and can provide insight into the molecular profile and biological characteristics of individual PDAC tumours, in real-time and in advance of traditional imaging modalities. This can pave the way for identification of new therapeutic targets, novel risk variants and markers of tumour response, to supplement diagnostic screening and provide enhanced scrutiny in treatment stratification. In the roadmap towards the application of precision medicine for clinical management in PDAC, ctDNA analyses may serve a leading role in streamlining candidate biomarkers for clinical integration. In this review, we highlight recent developments in the use of ctDNA-based liquid biopsies for PDAC and provide new insights into the technical, analytical and biological challenges that must be overcome for this potential to be realised. 相似文献
54.
55.
《Gaceta sanitaria / S.E.S.P.A.S》2016,30(6):451-456
ObjectiveThe main objective of this study is to define the factors associated with frailty and psychosocial imbalance in elderly people who live in the community.MethodsMulticentre prospective study with a representative sample of subjects older than 75 years who live in the community in the province of Huesca (Spain). 5-year follow-up with biannual assessment. Standardised individual assessment carried out by GPs trained to assess depression, anxiety, cognitive impairment, psychotic symptoms, sarcopenia, social network, dependence for basic and instrumental activities of daily living, physical severity, risk of dependence and quality of life. Further assessment two and five years later to quantify adverse events: institutionalisation, functional impairment or mortality. Possible risk factors will be assessed: gender, age, social status, functional status, mental status and physical severity. Predictive and individual risk models will be designed in order to identify elderly people with high psychosocial frailty and destabilisation risk.ConclusionsAn understanding of the possible risk factors would facilitate the identification of elderly subjects at greater risk of psychosocial frailty, thereby enabling preventive activities to be implemented aimed at reducing frailty and associated adverse events (institutionalisation, mortality, etc.). 相似文献
56.
Family-centered care (FCC) for sick newborns is emerging as a paradigmatic shift in the practice of facility-based newborn care. It seeks to transforming a provider-centered model into a client-centered one and thus build a new therapeutic alliance. FCC is the cornerstone of continuum of care, imparting caregiving competencies to parents/caregivers both within institutions as well as after the discharge. This has potential gains for the newborn, family members, and facility-level staff. The initial model piloted in tertiary-care settings is now undergoing translation at five sites across the country; the outcomes are keenly awaited. 相似文献
57.
58.
ObjectiveThis study used a prospective cohort study to observe the effect of triple-negative breast cancer on the 2-year disease-free survival rate with or without “TCM formula”.MethodsFrom November 1 st, 2016, the first patient was enrolled in the cohort study. A total of 356 patients were enrolled on January 30, 2019. Among them, 154 cases were followed up for 2 years. During the follow-up, there were 6 cases of shedding, so 6 cases were affected. A total of 148 cases were included in the analysis, including 73 in the exposed group and 75 in the non-exposed group. The exposed group was given “TCM formula” on the basis of standardized treatment, and the non-exposed group was treated with simple triple-negative breast cancer. The two groups visited each of the three months. The interview included safety examination (hematology and imaging). The endpoint was the difference in 2-year invasive disease-free survival between the exposed and non-exposed groups and the safety of the “TCM formula”.ResultsThere were 6 cases of shedding during the experiment and the shedding rate was 3.9 %. The 2-year rate of invasive disease-free survival in the exposed team was 88.7 % and the non-exposed group was 82.5 %. Logistic multivariate regression analysis predicted that “TCM formula” could reduce the disease-related recurrence and metastasis rate by 11 % (OR = 0.89, 95 % CI 0.37−0.956, P<0.05). Through K–M survival analysis, TNBC patients with age ≤35 years and regional lymph node stage N1 may be the benefit group of “TCM formula”(P<0.05). During the study, the incidence of total adverse events was 8.2 % in the exposed group, mainly manifested as stomach discomfort, diarrhea, and hepatocyte damage.Conclusion1. In the exposed group, the two-year rate of invasive disease-free survival increased by 6.2 % compared with the non-exposed group(P>0.05). 2. According to K–M survival analysis, TNBC patients with age ≤35 years and regional lymph node metastasis to N1 may be potential beneficiaries of “TCM formula”. 3. “TCM Formula” is safe and tolerable to most patients. 相似文献
59.
中西医结合治疗动眼神经麻痹疗效观察 总被引:2,自引:0,他引:2
李春林 《中国实用神经疾病杂志》2015,(10)
目的了解中西医结合法治疗动眼神经麻痹的临床疗效。方法对我院2012-03—2014-03收治的动眼神经麻痹患者进行抽样,择取74例患者随机分成2组,对照组予以基础性西医疗法,实验组在对照组治疗基础上予以中医疗法(包括针刺及服用中药正容汤等),观察2组患者的临床治疗效果。结果实验组总有效率(94.60%)明显高于对照组(64.86%),差异具有统计学意义(P0.05)。结论中西医结合法治疗动眼神经麻痹临床疗效确切,安全系数高,值得临床大力推广使用。 相似文献
60.
Sebastian P. Mondaca MD Dazhi Liu PharmD BCOP Jessica R. Flynn Sandy Badson Stefan Hamaway BS Mrinal M. Gounder MD Danny N. Khalil MD PhD Alexander E. Drilon MD Bob T. Li MD MPH Komal L. Jhaveri MD Alison M. Schram MD Katherine E. Kargus RN Mary Kate Kasler DNP MSN Natalie M. Blauvelt Neil H. Segal MD PhD Marinela Capanu PhD Margaret K. Callahan MD PhD David M. Hyman MD Maya Gambarin-Gelwan MD James J. Harding MD 《Cancer》2020,126(22):4967-4974